Home / Share Price Target / Berldrg
Beryl Drugs Share Price Target 2024, 2025, 2026 to 2039 With Charts
Beryl Drugs Limited | |||
 | Symbol: BERLDRG | ||
| Price: ₹32.75 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Beryl Drugs Financial Performance
- 0.1.1: Is Beryl Drugs A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Beryl Drugs Share Price Target For 2024
- 1.1.1: Beryl Drugs Share Price Target Table For 2024
- 1.1.2: Summary: Beryl Drugs Share Price Prediction For 2024
- 1.2: Beryl Drugs Share Price Target For 2025
- 1.2.1: Beryl Drugs Share Price Target Table For 2025
- 1.2.2: Summary: Beryl Drugs Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Beryl Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Beryl Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Beryl Drugs Past Performance
Beryl Drugs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 20.16 Crore | Market valuation of Beryl Drugs's shares. |
| Revenue (TTM) | 26.72 Crore | Total revenue generated by Beryl Drugs over the past twelve months. |
| Net Income (TTM) | +76.86 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 5.51% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 50.81% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +110.01% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 0.57 | Company's total debt divided by total shareholder equity. |
| Total Debt | 5.09 Crore | Sum of Beryl Drugs's current & long-term financial obligations. |
Is Beryl Drugs A Good Buy For Long Term?
Beryl Drugs, a small-cap stock with a market capitalization of ₹18.79 crore, shows significant growth potential but also carries considerable risk. While its 3-year and 5-year returns are impressive (324.90% and 267.47% respectively), recent quarterly revenue surged 110.01%, yet net profit remains relatively low at ₹76.86 lakh (50.81% profit margin). The existing debt of ₹5.09 crore is a concern. Given this volatility and the small market cap, it's currently an average buy for long-term investors with a high-risk tolerance. Further research into the drivers of revenue growth and debt management is crucial before making an investment decision.
To predict the Beryl Drugs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Beryl Drugs Share Price Target For 2024
The line chart displays the monthly closing prices of Beryl Drugs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Beryl Drugs shares in 2024, see the table below.
Beryl Drugs Share Price Target Table For 2024
| Beryl Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 33.65 (+2.74%) | Price Action: Feb 2013 High |
| 2024 Target 2 | 33.25 (+1.52%) | Price Action: 23 Oct 2024 Low |
| 2024 Target 1 | 32.85 (+0.3%) | Price Action: Oct 2014 High |
| Current Price | 32.75 | Beryl Drugs's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 32.01 (-2.26%) | Price Action: 19 Nov 2024 Low |
| Stop Loss 2 | 31.55 (-3.67%) | Fibonacci Retracement Level 98.6% |
| Stop Loss 3 | 31.20 (-4.74%) | Price Action: Dec 2015 Low |
Summary: Beryl Drugs Share Price Prediction For 2024
In summary, Beryl Drugs has surged by ₹10.18, achieving a notable +46.04% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Beryl Drugs for 2024 predicts an additional rise of 0.3% to 2.74% by the end of 2024 with three potential targets T1: 32.85, T2: 33.25, T3: 33.65. Stop Loss at SL1: 32.01, SL2: 31.55, SL3: 31.20.
Beryl Drugs has a 52-week high of ₹46.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹19.51, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Beryl Drugs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Beryl Drugs Share Price Target For 2025
The line chart displays the monthly closing prices of Beryl Drugs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Beryl Drugs shares in 2025, see the table below.
Beryl Drugs Share Price Target Table For 2025
| Beryl Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 50.35 (+53.74%) | Price Action: Chart |
| 2025 Target 2 | 49.41 (+50.87%) | Price Action: Chart |
| 2025 Target 1 | 48.92 (+49.37%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 32.75 | Beryl Drugs's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 28.40 (-13.29%) | Price Action: Jun 2013 High |
| Stop Loss 2 | 28.00 (-14.51%) | Price Action: Oct 2012 Low |
| Stop Loss 3 | 27.60 (-15.73%) | Price Action: Nov 2014 Low |
Summary: Beryl Drugs Share Price Prediction For 2025
In summary, Beryl Drugs has surged by ₹10.18, achieving a notable +46.04% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Beryl Drugs for 2025 predicts an additional rise of 49.37% to 53.74% by the end of 2025 with three potential targets T1: 48.92, T2: 49.41, T3: 50.35. Stop Loss at SL1: 28.40, SL2: 28.00, SL3: 27.60.
Beryl Drugs has a All-Time high of ₹53.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹19.51, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Beryl Drugs, we have created a specific page for that check here: Beryl Drugs Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Beryl Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Beryl Drugs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 10.46% over the next 15 years.
For complete year by year Beryl Drugs long term share price target from 2024, 2025 to 2039 check the below table.
Beryl Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Beryl Drugs Target | YoY Change % |
|---|---|---|
| 2024 | ₹32.75 | [Current Price] |
| 2024 | ₹32.86 | 0.36% |
| 2025 | ₹43.87 | 33.46% |
| 2026 | ₹51.54 | 17.48% |
| 2027 | ₹61.91 | 20.12% |
| 2028 | ₹64.03 | 3.42% |
| 2029 | ₹64.28 | 0.39% |
| 2030 | ₹79.08 | 23.02% |
| 2031 | ₹87.18 | 10.24% |
| 2032 | ₹99.52 | 14.15% |
| 2033 | ₹98.71 | -0.82% |
| 2034 | ₹95.7 | -3.05% |
| 2035 | ₹114.28 | 19.41% |
| 2036 | ₹122.82 | 7.47% |
| 2037 | ₹137.13 | 11.65% |
| 2038 | ₹133.38 | -2.74% |
| 2039 | ₹132.29 | -0.82% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Beryl Drugs Past Performance
- In 2005, Beryl Drugs opening price was ₹0.72
- As of Fri 22 Nov 2024 the price stands at ₹32.75.
- This represents a Compound Annual Growth Rate (CAGR) of 21.03%.
- In 19 years, an investment of 10,000 would have become ₹4.54 Lakh.
As we wrap up, we hope you like our study on Beryl Drugs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
